Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income 125 M57 M60 M112 M134 M54 M 360 M Non-Operating Income, Total 10 M017 M13 M18 M12 M 60 M Interest expense, net of interest capitalized 1 M01 M01 M0 2 M Non-Operating Income, excl. Interest Expenses 6 M6 M7 M16 M8 M8 M 39 M Unusual income/expense 3 M-6 M9 M-3 M9 M4 M 19 M Pretax income 91 M15 M31 M80 M105 M41 M 257 M Equity in earnings -3 M———2 M21 M — Taxes 12 M1 M2 M9 M13 M6 M 30 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 79 M14 M29 M71 M92 M35 M 227 M Discontinued operations —————— — Net income 79 M14 M29 M71 M92 M35 M 227 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 79 M14 M29 M71 M92 M35 M 227 M Basic earnings per share (Basic EPS) 0.980.170.360.871.110.43 2.77 Diluted earnings per share (Diluted EPS) 0.980.170.360.871.110.43 2.77 Average basic shares outstanding 80.22 M80.72 M81.23 M80.97 M82.34 M83.06 M — Diluted shares outstanding 80.31 M80.77 M81.28 M81.05 M82.35 M83.11 M — EBITDA 196 M129 M133 M185 M201 M122 M 641 M EBIT 125 M57 M60 M112 M134 M54 M 360 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 71 M72 M73 M73 M67 M68 M 281 M